PRESS-RELEASE ·Filed Nov 17, 2026
Press release · Contract
ERAS drugs
ERAS drug pipeline →Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3405323 |
Track record
27 reports on ERAS
4 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +95.35% at T+60 after the Apr 27, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 17, 2026today Press Release Bullish 5/10 Viewing Entry price pending
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $15.11 Now $13.89 −8.07% settles Feb 12
- Nov 16, 20261d ago SC 13G/A Neutral 2/10 Entry $15.11 Now $13.89 −8.07% settles Feb 12
- Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $15.11 Now $13.89 −8.07% settles Feb 12
- Nov 12, 20265d ago Press Release Neutral 4/10 Entry $15.66 Now $13.89 −11.30% settles Feb 11
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $14.64 Now $13.89 −5.12% settles Feb 1
- Oct 16, 20264w ago 8-K Neutral 2/10 Entry $13.39 Now $13.89 +3.73% settles Jan 13
- Aug 24, 202612w ago 8-K Bullish 5/10 Entry $17.60 to $13.89 Now $13.89 −21.08% ▼ −21.08% −17.02% vs SPY
- Aug 17, 202613w ago 144 Neutral 3/10 Entry $18.28 to $15.61 Now $13.89 −24.02% ▼ −14.61% −11.84% vs SPY
- Aug 13, 202613w ago Institutional Cluster Bullish 6/10 Entry $17.86 to $14.41 Now $13.89 −22.23% ▼ −19.32% −13.84% vs SPY
Showing 10 of 27
US Market Status
Market Closed · Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers